What's breaking now, across thousands of outlets.
IonQ has "multiple ways to win" but investors are paying for growth that is not yet realized.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.
MONACO, Sept. 28, 2026 (GLOBE NEWSWIRE) — With more than 17,000 islands, hundreds of ethnic groups and one of the world’s richest marine environments, Indonesia sees maritime tourism as a major…
Moderna has the clinical lead, while BioNTech has the deeper war chest. See which cancer stock offers the stronger long-term setup as mRNA oncology enters a new phase.